The Reagan-Udall Foundation for the FDA, in support of the Agency’s ongoing focus on understanding the medical need for PTSD treatment to facilitate treatment development, will convene “Advancing Treatments for Post-Traumatic Stress Disorder,” a public meeting with stakeholder

Roughly 13 million Americans are suffering from PTSD today, or about 6% of the population. Many patients, therapists, and advocates were hopeful for the FDA approval of MDMA-assisted therapy for PTSD—and yet, "the FDA administrators were not comfortable approving despite the

International Overdose Awareness Day is a time to remember the lives we've lost to overdose and reflect on how we can prevent more tragedies. In honor of this day, MAPS is teaming up with @SSDPofficial to share essential harm reduction tips that could make all the difference.

📣 Calling all PTSD advocates, veterans, researchers: U.S. FDA wants to hear from you! Public meeting on new PTSD treatments, inc. psychedelics, Sept 6. Register TODAY: reaganudall.org/news-and-event… Submit written comments by September 20th! Your voice matters❤️

September is Suicide Prevention Awareness Month—a time to reflect on the impact of suicide and the importance of mental health support.🩵💜 If you or someone you know is struggling, remember that you are not alone. We encourage you to seek help by exploring these support

Psychedelics are often misinterpreted, surrounded by myths and misconceptions. Understanding their transformative potential is essential for personal growth and healing. 🌱✨ How can we come together as a community to spread more awareness and truth about psychedelics? How can

In honor of International Literacy Day, we celebrate the power of education in transforming lives—something we hold close to our mission at MAPS✨📚. By spreading knowledge about psychedelics and mental health, we aim to empower individuals and advance healing for all. To

We’re excited to share exclusive insights from the Reagan Udall Foundation for FDA's hybrid public meeting, Advancing Treatments for PTSD. This important event brought together leading trauma therapy experts to discuss the urgent need for more innovative PTSD therapies.

Last week, The Reagan-Udall Foundation for the FDA held a meeting on the urgent need for novel therapies, including the potential of psychedelic-assisted therapy for treating PTSD. Following the meeting, MAPS held a press briefing featuring Betty Aldworth, Dr. Michael

The Polaris Insight Center KAP Cohort is underway, and there's still time to join! This virtual training covers the essentials of Ketamine-Assisted Psychotherapy (KAP), blending online educational modules with group discussions. Clinicians will gain confidence in Ketamine-Assisted

Like a psychedelic journey, Climate Week inspires big dreams, profound revelations, and ambitious plans. Without the right preparation and integration, these powerful experiences can slip away as daily life resumes. Psychedelic-Climate Week offers frameworks and supportive

"How a Waynesville Clinic Is Using MDMA To Treat PTSD," by Emma Castlebury from The Assembly, covers The Pearl Psychedelic Institute Institute's involvement as a clinical trial site for MDMA-assisted therapy for PTSD and follows one of the participants' experiences working through his PTSD.

In a recent press briefing, Dave Rabin compared MDMA-assisted therapy to major pharmaceutical breakthroughs. New treatments often face skepticism and regulatory hurdles. MDMA-assisted therapy, despite its potential for PTSD, encounters similar resistance due to challenges in